NL-OMON55698招募中3 期
SOUL: Semaglutide cardiovascular outcomes trial in patients with type 2 diabetes - SO
ovo Nordisk0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •-Male or female, age >=50 years at the time of signing informed consent
- •-Diagnosed with type 2 diabetes mellitus
- •-HbA1c 6.5% - 10.0% (47 - 86 mmol/mol) (both inclusive)
- •-At least one of the below conditions (a-d):
- •a) Coronary heart disease
- •b) Cerebrovascular disease
- •c) Symptomatic peripheral artery disease (PAD)
- •d) Chronic kidney disease
排除标准
- •-Any of the following: myocardial infarction, stroke, hospitalisation for
- •unstable angina pectoris or transient ischaemic attack within the past 60 days
- •prior to the day of screening
- •-Planned coronary, carotid or peripheral artery revascularisation known on the
- •day of screening
- •-Heart failure presently classified as being in New York Heart Association
- •-Treatment with any glucagon-like peptide-1 receptor agonist within 30 days
- •before screening
研究者
相似试验
进行中（未招募）
1 期
A heart disease study of semaglutide in patients with type 2 diabetesMedDRA version: 21.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861Diabetes Mellitus, Type 2EUCTR2018-003141-42-SKovo Nordisk A/S9,642
进行中（未招募）
1 期
A heart disease study of semaglutide in patients with type 2 diabetesDiabetes Mellitus, Type 2EUCTR2018-003141-42-FRovo Nordisk A/S9,642
进行中（未招募）
1 期
A heart disease study of semaglutide in patients with type 2 diabetesDiabetes Mellitus, Type 2EUCTR2018-003141-42-GBovo Nordisk A/S9,642
进行中（未招募）
1 期
A heart disease study of semaglutide in patients with type 2 diabetesDiabetes Mellitus, Type 2EUCTR2018-003141-42-ESovo Nordisk A/S9,642
进行中（未招募）
1 期
A heart disease study of semaglutide in patients with type 2 diabetesMedDRA version: 21.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861Diabetes Mellitus, Type 2EUCTR2018-003141-42-CZovo Nordisk A/S9,642